AstraZeneca said on Tuesday it would sell rights to its erstwhile blockbuster cholesterol drug, Crestor, to German pharmaceutical company Gruenenthal GmbH for an upfront payment of $320 million as the British drugmaker focuses on its cancer treatments portfolio.
AstraZeneca's blood cancer treatment, Calquence, failed to improve survival rates and prevent lung failure in patients hospitalised with symptoms of COVID-19, the drugmaker said on Thursday, citing results from mid-stage trials.
Property developer Great Portland Estates on Wednesday reported an 18% plunge in the valuation of its retail portfolio as coronavirus restrictions hit the industry, and said office take-up in central London had dropped to record lows.
* Expects rents and capital value to fall further in London
(Adds details on the results, background, shares)
* Like-for-like net rental income down 10%
(Adds analyst comment, shares)
Britain's Countrywide Plc has been approached by real estate management firm Connells Ltd about a possible buyout that would value the real estate agent at around 82 million pounds ($108 million).
LONDON J D Wetherspoon accused the British government of panicking and "shooting from the hip" with new coronavirus restrictions it said could damage the entire economy, after the pubs group reported its first annual loss since 1984.
* Rival Marston's warned this week 2,150 jobs at risk
(Adds additional quotes from Martin, updates shares)
Weir Group Plc said on Monday it had agreed to sell its oil and gas division to U.S. heavy equipment maker Caterpillar Inc for $405 million in cash, as the engineering company focuses on its mining business.
Security group G4S on Wednesday rejected a cash offer by smaller Canadian rival GardaWorld that valued the British company at 2.97 billion pounds ($3.81 billion), weeks after it turned down a similar proposal.